Clinical trial
Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine…
NCT00204659 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00204659 |
|---|---|
| Title | Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma |
| Official title | Phase II Study With Rituximab and CHOP in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma |
| Lead sponsor | University Hospital Tuebingen, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Primary Gastric Diffuse-Large B-Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Rituximab + CHOP chemotherapy |
| Enrollment | 30 |
| Start date | Mar 1, 2003 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 20, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: